NEW YORK (GenomeWeb) – Grail and Cirina, two startups looking to commercialize liquid biopsy tests for early cancer detection, have decided to join forces.
Cirina, which was founded by Dennis Lo of the Chinese University of Hong Kong and raised $12 million in a Series A financing round in 2014, will operate as a subsidiary of Grail.